Abstract
The comparison of activities of the key enzymes of androgen metabolism in morphological variants of bone sarcomas and benign tumors suggests that malignant tumors of different histogenesis not only metabolize the main androgen testosterone, but also inactivate 5α-dihydrotestosterone, the main regulatory androgen in bones. It is possible that androgen metabolism in bone tumors is aimed at the formation of other androgens, in particular, 3α-and 5β-diols, which can be involved in regulatory processes in bone tissue. Further studies will disclose clinical significance of androgen metabolism and individual androgens in human bone tumors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
